Ready to redefine what's possible in molecular diagnostics?
Join a team of brilliant, passionate innovators determined to transform healthcare. At BillionToOne, we've built a category-defining, publicly traded company on Nasdaq where transparency fuels trust, collaboration drives breakthroughs, and every contribution moves the needle on our mission to make life-changing diagnostics accessible to all. We don't just aim for incremental improvements; we build products that are 10x better than anything that exists today.
Our scientists, engineers, sales executives, and visionaries are united by an unwavering commitment to changing the standard of care in prenatal and cancer diagnostics. This is where cutting-edge science meets human compassion, and every innovation you contribute helps remove the fear of the unknown from some of life's most critical medical moments.
If you're driven by purpose, energized by innovation, and ready to help shape the future of precision medicine at scale, this is where you belong.
BillionToOne is seeking a Product Management Intern (Software Engineering) to support objectives in the oncology product portfolio (Northstar Select and Response). This person will work to define user requirements and pain points, develop a product roadmap, and execute a successful launch. The ideal candidate will be independent, metrics-driven, and comfortable interfacing with a diverse group of stakeholders.
Responsibilities
Requirements
Benefits And Perks:
At BillionToOne, we are proud to offer a combination of competitive base pay, and the opportunity for professional growth.
For this position, the base pay rate is $25 per hour.
BillionToOne is an equal opportunity employer. We do not discriminate on the basis of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status.
For more information about how we protect your information, we encourage you to review our Privacy Policy.
BillionToOne is a next-generation molecular diagnostics company on a mission to make powerful, accurate diagnostic tests accessible to everyone. Our revolutionary QCT molecular counting technology enhances disease detection resolution by over a thousandfold using cell-free DNA, a breakthrough that has already transformed the lives of over half a million patients worldwide.